Imat Imatinib Mesylate 400 mg
Imatinib Mesylate 400 mg treats various cancers, including blood cancers like chronic myeloid leukemia.
In stock
Description
The tablet is prescribed for the treatment of various cancer types, primarily blood cancers such as chronic myeloid leukemia and acute lymphocytic leukemia, along with gastrointestinal stromal tumors. Its mechanism of action involves targeting specific proteins responsible for the growth and dissemination of cancer cells.
Additional information
| Drug Composition | Imatinib Mesylate 400 mg |
|---|---|
| Variant/Strength | 400 mg |
| Dosage Form/Type | Capsules |
| Product Benefits | Treatment of Cancer |
| Packaging | Strip |
| Delivery Time | 7 – 15 Days, as per delivery location. |
| Country of Origin | Made in India |
Reviews
There are no reviews yet.